Researchers Develop a ‘Sweet’ Strategy for Targeted Cancer Therapeutics
Researchers have demonstrated a novel two-step strategy to label and eradicate cancer stem-like cells (CSC) to improve cancer treatment prognosis.
Researchers have demonstrated a novel two-step strategy to label and eradicate cancer stem-like cells (CSC) to improve cancer treatment prognosis.
Scientists often build new protein molecules by stringing groups of amino acids together. These amino acid chains, called polypeptides, are the building blocks needed in drug development and the creation of new biomaterials.
Bacteria have many methods of adapting to resist antibiotics, but a new class of spiral polypeptides developed at the University of Illinois targets one thing no bacterium can live without: an outer membrane.